aqst stock forecast zacks
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to 40 Million with Lincoln Park Capital. The specialty pharmaceutical company posted revenue of.
Stock Quotes Crbp Welcome Guest
Based on short-term price targets offered by three analysts the average price target for Aquestive Therapeutics comes to 633.
. The forecasts range from a low of 400 to. Find the latest Price for Aquestive Therapeutics AQST. Price is a widely used stock evaluation measure.
According to 13 stock analysts the average 12-month stock price forecast for AQST stock is 648 which predicts an increase of 64483. The lowest target is 303 and. WARREN NJ April 13 2022 GLOBE NEWSWIRE --.
For the Aquestive Therapeutics Inc forecast traded under symbol AQST for one year forward price target at the top of this page we have presented the average AQST forecast for forward. Rooms Rankings Earnings Newsletters Shop. Real-time trade and investing ideas on Aquestive Therapeutics Inc AQST from the largest community of traders and investors.
The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
Aqst
Where Aquestive Therapeutics Stands With Analysts Aquestive Therapeutics Nasdaq Aqst Benzinga
A Deep Dive Into Aquestive Following The Fda S Approval Of Riluzole
Aquestive Therapeutics Nasdaqgm Aqst Share Price News Analysis Simply Wall St
A Deep Dive Into Aquestive Following The Fda S Approval Of Riluzole
Aqst
A Deep Dive Into Aquestive Following The Fda S Approval Of Riluzole
Aquestive Therapeutics Reports Positive Topline Data From Part 2 Of Epiphast Trial Evaluating Aqst 109 Epinephrine Oral Film
Stock Research Ratings Zacks Com
Aquestive Therapeutics Sell Off Prompts A Change In Tactics Nasdaq Aqst Seeking Alpha
Aquestive Therapeutics Sell Off Prompts A Change In Tactics Nasdaq Aqst Seeking Alpha
47392447 15773789772774827 Png
Aquestive Therapeutics Sell Off Prompts A Change In Tactics Nasdaq Aqst Seeking Alpha
Rax4wor8l 34vm
Aquestive Therapeutics Q3 Earnings Snapshot
Aquestive Therapeutics Libervant Will Eventually Be Approved Says Analyst Nasdaq
Aquestive Therapeutics Q3 Earnings Snapshot
Aquestive Therapeutics Q3 Earnings Snapshot
Taking Stock Of The Impressive Earnings Picture August 11 2021 Zacks Com